SAN JOSE, Calif., Feb. 14, 2018 -- CloudGenix, the leader in Software-Defined Wide Area Networking (SD-WAN), has announced that industry veteran and WAN innovator Mukhtiar Shaikh has been appointed Chief Technology Officer of the company. Prior to this appointment, Mr. Shaikh has served as the Chief Architect at CloudGenix, providing leadership on product and solution architecture, and working with global accounts to design and successfully deploy CloudGenix AppFabric at scale.
Prior to CloudGenix, Mr. Shaikh served as a Distinguished Engineer at Cisco Systems, a title that is reserved for the absolute elite in networking. Additionally, Mr. Shaikh was a Distinguished Network Architect at Brocade Communications. Mr. Shaikh is considered a domain expert in many Wide Area Networking technologies including MPLS, BGP, virtualization, and software-defined networking. Mr. Shaikh is the author of and contributor to several patents on these topics.
Regarding the announcement, Mr. Shaikh said, “I’m delighted to be named Chief Technology Officer of a company that is so rapidly dismantling the WAN market with industry’s first Gen2 SD-WAN solution. We’re creating material value for our customers daily by giving them an easier and cost effective way of deploying and managing their WAN, aligning with their objectives for performance, security, and compliance. I look forward to further innovating in this space in my new capacity at CloudGenix.”
Kumar Ramachandran, CEO at CloudGenix, said, “Mukhtiar is a visionary and a legend in the field of networking. He’s had a decorated history at name-brand networking companies like Cisco and Brocade, and provided immense value to our customers through his out-of-the-box thinking. Creativity can be super-charged when you’re an expert in your domain, and Mukhtiar exemplifies this. We are ecstatic with the accomplishments he was able to drive for CloudGenix and moreso for what the future holds.”
About CloudGenix
CloudGenix (www.cloudgenix.com) is the software-defined wide-area network (SD-WAN) leader, revolutionizing networking by transforming legacy WANs into a radically simplified, secure, application-defined fabric and unified hybrid WAN. Enabling application-specific, service-level agreements (SLAs), CloudGenix controls network application performance based upon application-performance SLAs and business priority. CloudGenix ION (Instant-On Network) simplifies how WANs are designed and managed, enabling customers to build “networks without networking,” and achieve more than twice the performance at less than half the cost while extending data center-class security to the network edge. Founded in 2013 by a team that has delivered industry-leading products in networking, SDN, cloud, security and web-scale applications, CloudGenix serves world-class financial services, legal, retail and technology organizations.
Contact
CloudGenix
[email protected]


SpaceX Prioritizes Moon Mission Before Mars as Starship Development Accelerates
DBS Expects Slight Dip in 2026 Net Profit After Q4 Earnings Miss on Lower Interest Margins
SoftBank Shares Slide After Arm Earnings Miss Fuels Tech Stock Sell-Off
American Airlines CEO to Meet Pilots Union Amid Storm Response and Financial Concerns
SpaceX Pivots Toward Moon City as Musk Reframes Long-Term Space Vision
Rio Tinto Shares Hit Record High After Ending Glencore Merger Talks
Anta Sports Expands Global Footprint With Strategic Puma Stake
Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing
Kroger Set to Name Former Walmart Executive Greg Foran as Next CEO
Amazon Stock Rebounds After Earnings as $200B Capex Plan Sparks AI Spending Debate
Global PC Makers Eye Chinese Memory Chip Suppliers Amid Ongoing Supply Crunch
Once Upon a Farm Raises Nearly $198 Million in IPO, Valued at Over $724 Million
OpenAI Expands Enterprise AI Strategy With Major Hiring Push Ahead of New Business Offering
American Airlines CEO to Meet Pilots Union Amid Storm Response and Financial Concerns
FDA Targets Hims & Hers Over $49 Weight-Loss Pill, Raising Legal and Safety Concerns
Innovent Biologics Shares Rally on New Eli Lilly Oncology and Immunology Deal
Indian Refiners Scale Back Russian Oil Imports as U.S.-India Trade Deal Advances 



